Edwards Lifesciences Corp EW 价格预测与展望

Q: EW 的斐波那契回调水平是多少？

Edwards Lifesciences Corp 的斐波那契回调水平是 在 61.8% 和 78.6% 之间。

Q: Edwards Lifesciences Corp 的 RSI 是多少？

Edwards Lifesciences Corp 的 RSI 目前为 55.60，表明处于 中立 状态



预测

EW 股票价格预测

Edwards Lifesciences Corp

$82.28

-1.41%

$-1.17

收盘价：Apr 28, 16:00:00 GMT-4

$81.9

-0.46%

$-0.37

盘前：Apr 29, 09:28:14 GMT-4

概述预测财报股息财务数据

关键数据

前收盘价

$83.46

开盘价

$84.35

当日区间

$81.51 - $84.95

52周范围

$68.63 - $87.89

交易量

5.0M

平均成交量

4.2M

股息收益率

每股收益（TTM）

1.83

市值

$47.2B

什么是 EW？

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 16,000 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

功能特性

Markets

News

使用条款隐私政策

According to analyst forecasts, we anticipate notable price fluctuations for EW in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $97.94. The lowest target is $85.6 and the highest is $115.5. Empower your investment choices with our cutting-edge, data-driven analysis!

EW 股价预测摘要

EW的顶级分析师评级

基于 43 位分析师对 EW 的股票评级，更新于 Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for EW. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: EW is a Buy candidate.

EW stock price ended at $82.28 on 星期二, after dropping 1.41%

On the latest trading day Apr 28, 2026, the stock price of EW fell by 1.41%, dropping from $84.13 to $82.28. During the session, the stock saw a volatility of 4.22%, with prices oscillating between a daily low of $81.51 and a high of $84.95. On the latest trading day, the trading volume for EW decreased by 1.3M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 5.8M shares were traded, with a market value of approximately $47.4B.

EW 技术面信号

技术面信号摘要

买入信号 3

中性信号 1

卖出信号 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

EW目前显示3个买入信号和3个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-2.22%。总体而言，技术指标显示中期前景为Neutral。

EW 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 EW 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 EW？



根据技术分析，Edwards Lifesciences Corp 的综合信号为 Neutral。Edwards Lifesciences Corp 有 3 个买入信号，1 个中性信号和 3 个卖出信号。

EW 的斐波那契回调水平是多少？



Edwards Lifesciences Corp 的斐波那契回调水平是在 61.8% 和 78.6% 之间。

Edwards Lifesciences Corp 的 RSI 是多少？



Edwards Lifesciences Corp 的 RSI 目前为 55.60，表明处于中立状态

Edwards Lifesciences Corp 接下来 12 个月的价格是多少？



Edwards Lifesciences Corp EW 接下来 12 个月的价格预计为 $97.94。

Edwards Lifesciences Corp 预计会涨到多高？



据华尔街分析师称，Edwards Lifesciences Corp 预计将达到 $115.5 的高预测值。

Edwards Lifesciences Corp (EW) 股票价格预测

EW 股价走势图